Switch to
More onapp

Pfizer Ltd

PFIZER
Health CarePharmaceuticals
MidcapWith a market cap of ₹18,326 cr, stock is ranked 241
Low RiskStock is 1.06x as volatile as Nifty
4,001.559.40 (-0.23%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
MidcapWith a market cap of ₹18,326 cr, stock is ranked 241
Low RiskStock is 1.06x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
29.92
PB RatioPB Ratio
6.40
Dividend YieldDiv. Yield
0.87%
Sector PESector PE
34.15
Sector PBSector PB
4.18
Sector Div YldSctr Div Yld
0.92%

Forecast & RatingsDetailed Forecast 

83%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Pfizer Limited is a pharmaceutical company. The Company has a portfolio of approximately 140 products across over 15 therapeutic areas.

Brands

Pfizer

Pharmaceutical company

Brands

Pfizer

Pharmaceutical company

Financial TrendFinancial statements 

20192020202120222.252.342.322.670.430.510.500.61
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Certificate under SEBI (Depositories and Participants) Regulations, 2018 
Announced OnJan 6, 2023

In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we furnish herewith Certificate dated January 6, 2023, issued by KFin Technologies Limited, Registrar and Share Transfer Agent of the Company for the quarter ended December 31, 2022. | Download

In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we furnish herewith Certificate dated January 6, 2023, issued by KFin Technologies Limited, Registrar and Share Transfer Agent of the Company for the quarter ended December 31, 2022. | Download

Trading Window 
Announced OnDec 30, 2022

Pfizer Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 | Download

Pfizer Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 | Download

Cash Dividend 
Ex. DateSep 19, 2022

Special • Div/Share: ₹ 30

See all events